Company Number: 15265381

Analysis Date: 2025-07-29 13:41 UTC

Financial Health Assessment of HMB PHARMA LTD

---

1. Financial Health Score: D

Explanation:
The company is in a very early stage with dormant status, minimal financial activity, and negligible asset base (£100). This indicates a fragile financial condition typical of a newly formed company that has yet to commence trading or generate revenue. The score reflects caution, as the company currently exhibits "symptoms" of financial inactivity and no operational cash flow.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Age	~1 year	Newly incorporated, implying limited financial history or operational track record
Account Category	Dormant	No significant financial transactions or trading activity to date
Current Assets	£100	Minimal cash or equivalents; very low liquidity
Net Current Assets	£100	Positive but trivial working capital; no buffer for operating expenses
Net Assets (Shareholders' Funds)	£100	Equity reflects initial share capital only; no retained earnings or reserves
Employees	0	No workforce; no payroll obligations or operational overheads
Director Ownership	75-100% by Mr Hurkamal Michael Badhan	Single controlling shareholder/director, simplifying decision-making but concentration risk
Industry SIC Code	70100 (Activities of head offices)	Likely holding or management entity; no direct trading or production activities yet
Filing Status	Up to date	Compliance with statutory filing deadlines, indicating good governance in terms of legal obligations

---

3. Diagnosis: What the Financial Data Reveals

The company presents as a "healthy newborn" in terms of statutory compliance but medically classified as dormant with "symptoms of inactivity." The balance sheet shows a nominal asset base represented by initial share capital (£100). There are no signs of operational revenue, expenses, or workforce deployment, indicating that the business has not commenced active trading or commercial operations.

The absence of liabilities is a positive sign—no debts or creditors—meaning no immediate financial distress. However, the lack of operating assets or income-producing activities means the company currently has no "circulatory system" (cash flows) to sustain itself beyond the initial capital.

The director and sole shareholder have full control, which allows for swift decisions but also concentrates risk. The company’s classification under SIC 70100 suggests it may function as a holding or management company, which can be a strategic structure but currently lacks operational substance.

---

4. Recommendations: Path to Improved Financial Wellness

• Activate Business Operations: To transition from dormant status to active trading, the company should initiate its core business activities, generating revenue and establishing working capital cycles.

• Build Cash Reserves: Increase current assets beyond the nominal £100 to maintain a healthy cash flow buffer, ensuring the company can meet operational expenses as they arise.

• Develop a Financial Plan: Prepare a detailed budget and cash flow forecast to monitor inflows and outflows, enabling early detection of financial "symptoms" such as cash shortages or excessive liabilities.

• Consider Capital Injection: If operational plans require upfront investment, consider additional equity funding or loans to strengthen the balance sheet and liquidity.

• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain corporate reputation.

• Evaluate Business Model: If the company is intended as a holding entity, clarify its strategic role and ensure appropriate financial and legal structuring.

---